Skip to main content

Published locations for Caplacizumab approved in Europe to treat aTTP

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Caplacizumab approved in Europe to treat aTTP

User login

  • Reset your password
  • /content/caplacizumab-approved-europe-treat-attp
  • /familypracticenews/article/174047/bleeding-disorders/caplacizumab-approved-europe-treat-attp
  • /hematologynews/article/174047/bleeding-disorders/caplacizumab-approved-europe-treat-attp
  • /internalmedicinenews/article/174047/bleeding-disorders/caplacizumab-approved-europe-treat-attp
  • /hematology-oncology/article/174047/bleeding-disorders/caplacizumab-approved-europe-treat-attp
  • /internalmedicine/article/174047/bleeding-disorders/caplacizumab-approved-europe-treat-attp
  • /familymedicine/article/174047/bleeding-disorders/caplacizumab-approved-europe-treat-attp